Effects of Exercise in Patients With Repaired Coarctation of the Aorta (KOREKT)
Effects of Exercise on Select Indicators of Cardiovascular Health in Patients With Repaired Coarctation of the Aorta
This interventional study will investigate the effects of high-intensity interval training (HIIT) in adults with repaired coarctation of the aorta. Participants will be randomised into three groups: HIIT performed at home, HIIT performed in a supervised outpatient setting, or a control group receiving usual care. The two HIIT protocols will be identical in intensity and progression, individually prescribed for each patient.
The study will evaluate the effects of HIIT on exercise capacity, health-related quality of life, blood pressure response to exercise, and other select measures of cardiovascular health, including vascular stiffness and endothelial function. In addition, the study will examine the acute effects of a single exercise session on arterial stiffness.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Ljubljana, Slovenia, 1000
- University Medical Centre Ljubljana
-
Maribor, Slovenia, 2000
- University Medical Centre Maribor
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- surgically repaired coarctation of the aorta,
- age at least 18 years, and
- signed informed consent form.
Exclusion Criteria:
- residual aortic stenosis (gradient across the narrowing >20 mmHg),
- presence of ascending aortic aneurysm,
- recent major cardiovascular event or other event requiring hospitalization (event less than 2 months before inclusion),
- unstable rhythm disturbances,
- unstable or low-threshold angina pectoris,
- NYHA class III or IV heart failure, and
- pregnancy.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Outpatient HIIT
Anticipated number of patients: 15. Participants will complete a structured high-intensity interval training (HIIT) programme performed in an outpatient setting. Intensity and progression are identical to the home-based HIIT arm. |
A structured exercise programme performed under direct supervision in an outpatient/clinical setting on a stationary bicycle or treadmill, consisting of 36 one-hour sessions over 2-4 months (approximately 2-3 sessions per week). Each session will comprise 8 five-minute intervals, each consisting of 2 minutes at 85-95% of the heart rate reached at VO2peak, followed by 3 minutes of active recovery. The interval block will be preceded by a 5-minute active warm-up and followed by a 5-minute active cool-down. Interval intensity will be individually determined for each patient. |
|
Sperimentale: Home-based HIIT
Anticipated number of patients: 15. Participants will complete a structured high-intensity interval training (HIIT) programme performed independently at home. Intensity and progression are identical to the outpatient HIIT arm. |
A structured exercise programme performed independently at home, consisting of 36 one-hour sessions over 2-4 months (approximately 2-3 sessions per week). Each session will comprise 8 five-minute intervals, each consisting of 2 minutes at 85-95% of the heart rate reached at VO2peak, followed by 3 minutes of active recovery. The interval block will be preceded by a 5-minute active warm-up and followed by a 5-minute active cool-down. Interval intensity will be individually determined for each patient. |
|
Nessun intervento: Control (usual care)
Anticipated number of patients: 15. Participants will receive usual care, consisting of general counselling on physical activity performed at home, without a structured or supervised exercise training programme. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
VO2peak on cardiopulmonary exercise testing (CPET)
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Hypothesis: The outpatient high-intensity interval training (HIIT) programme improves aerobic capacity (measured by VO2peak) more than a home-based HIIT program or usual care.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Health-related quality of life
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Hypothesis: The outpatient high-intensity interval training (HIIT) programme improves health-related quality of life, assessed using the standardised SF-36 and EQ-5D questionnaires, more than a home-based HIIT programme or usual care.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Ratio of peak systolic blood pressure to peak workload (mmHg/W) on CPET
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Hypothesis: The outpatient high-intensity interval training (HIIT) programme reduces the ratio between peak systolic blood pressure and peak workload achieved during exercise testing more than a home-based HIIT programme or usual care.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean 24-hour systolic blood pressure
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of average systolic pressure during sleep and wakefulness, measured using 24-hour ambulatory blood pressure monitoring.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Echocardiographic parameters
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of standard echocardiographic measures of cardiac structure and function, including left ventricular global longitudinal strain (GLS).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Endothelial function of the right radial artery (flow-mediated dilation, FMD)
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Ultrasound assessment of endothelial function of the right radial artery, measured by flow-mediated dilation (FMD).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Heart rate variability
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of heart rate variability using high-resolution electrocardiography.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Biomarkers associated with vascular stiffness and atherosclerosis
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of circulating biomarkers associated with vascular stiffness and atherosclerosis, including atrial natriuretic peptide (ANP), growth/differentiation factor 15 (GDF-15), matrix metalloproteinase 1 (MMP-1), interleukin-33 receptor (IL-33/ST2), brain-derived neurotrophic factor (BDNF), galectin-3, myeloperoxidase, and tissue inhibitor of metalloproteinase 1 (TIMP-1).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Self-reported physical activity
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Self-reported physical activity level, assessed using the standardised International Physical Activity Questionnaire (IPAQ).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Body composition
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of body composition using bioelectrical impedance analysis.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Standard laboratory panel
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of standard laboratory parameters: electrolytes, renal function markers, liver function tests.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
NT-proBNP
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of NT-proBNP
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Extended lipid panel
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment extended lipid panel, including Lp(a).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Thyroid hormone level
Lasso di tempo: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of thyroid hormones.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Collaboratori e investigatori
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 0120-101/2025-2711-4
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- ICF
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .